» Authors » Sarah Gekeler

Sarah Gekeler

Explore the profile of Sarah Gekeler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 35
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stanger A, Arnone M, Hanns P, Kimmich L, Kubler J, Gekeler S, et al.
Haematologica . 2025 Jan; PMID: 39781615
In acute myeloid leukemia (AML), leukemogenesis depends on cell-intrinsic genetic aberrations and thus, studies on AML require investigations in an in vivo setting as provided by patient derived xenografts (PDX)...
2.
Gunter M, Mueller K, Salazar M, Gekeler S, Prang C, Harm T, et al.
Eur J Immunol . 2024 Aug; 54(11):e2451145. PMID: 39094122
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection can lead to life-threatening clinical manifestations. Patients with cardiovascular disease (CVD) are at higher risk for severe courses of COVID-19. So...
3.
Mueller K, Langnau C, Harm T, Sigle M, Mott K, Droppa M, et al.
Arterioscler Thromb Vasc Biol . 2024 Jul; 44(9):2118-2135. PMID: 38989580
Background: Aortic stenosis (AS) is driven by progressive inflammatory and fibrocalcific processes regulated by circulating inflammatory and valve resident endothelial and interstitial cells. The impact of platelets, platelet-derived mediators, and...
4.
Harm T, Rath D, Kreisselmeier K, Baas L, Prang C, Gekeler S, et al.
Thromb Res . 2023 Aug; 230:45-54. PMID: 37634310
Background: Intracoronary thrombus formation is a main cause of acute myocardial infarction triggered by platelet activation. However, there are no data on the impact of different treatment strategies with antiplatelet...
5.
Langnau C, Janing H, Kocaman H, Gekeler S, Gunter M, Petersen-Uribe A, et al.
Biomarkers . 2022 Nov; 28(1):97-110. PMID: 36377411
Introduction: Patients with cardiovascular disease (CVD) and acute SARS-CoV-2 infection might show an altered immune response during COVID-19. Material And Methods: Twenty-three patients with CVD and SARS-CoV-2 infection were prospectively...
6.
Langnau C, Rohlfing A, Gekeler S, Gunter M, Poschel S, Petersen-Uribe A, et al.
Arterioscler Thromb Vasc Biol . 2021 Apr; 41(6):2080-2096. PMID: 33910372
[Figure: see text].
7.
Mueller K, Langnau C, Gunter M, Poschel S, Gekeler S, Petersen-Uribe A, et al.
Cardiovasc Res . 2020 Nov; 117(1):224-239. PMID: 33188677
Aims: To elucidate the prognostic role of monocytes in the immune response of patients with coronary artery disease (CAD) at risk for life-threatening heart and lung injury as major complications...
8.
Mueller K, Patzelt J, Sauter M, Maier P, Gekeler S, Klingel K, et al.
ESC Heart Fail . 2018 Sep; 5(5):846-857. PMID: 30168657
Aim: The aim of this study is to analyse the prognostic value of complement anaphylatoxin receptors in patients with non-ischaemic cardiomyopathy undergoing endomyocardial biopsy. Methods And Results: In 102 patients...